Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Sanuwave Insider Trading Activity: Who Would Buy This Stock?

Sanuwave insider trading: On Wednesday, October 9, Joseph Chiarelli, Chief Executive Officer at SANUWAVE Health, Inc. (OTCBB:SNWV) purchased 41,667 shares of common stock, at a price of $0.60 each, for a total transaction worth $25,000 approximately. This is Mr. Chiarelli’s first acquisition in the company and represents an investment capital worth $30,000.

Sanuwave Health

Mr. Chiarelli’s purchase was accompanied by Barry J. Jenkins’ acquisition of 13,500 shares of common stock, at a price of $0.74 for a total transaction worth $9,990. Mr. Jenkins is Chief Financial Officer at Sanuwave Health, and his position now stands at 215,742 shares of common stock, representing a capital investment worth $155,334. His previous acquisition dates from December 30, 2011, for a total of 48,500 shares of common stock, at a price of $0.18 each.

Kevin A. Richardson, Director at Sanuwave Health, was the third company member completing an acquisition on October 9. His transaction entailed 35,312 shares of common stock, at a price of $0.60 each, for a total acquisition worth $21,187 approximately. Now, Mr. Richardson holds a total of 1,583,316 shares of common stock, for a total capital investment of $1,139,987.

The stock has been unable to reach this year’s high price of $1.42 recorded on April 12, and is well behind the historical high of $5.72 registered on April 1, 2011. Since June, the stock price has oscillated between $0.59 and $0.80, and no clear uptrend has been identified. Also, dividend payments have been suspended and cash flow has been on the negative for the past four years, and debt continues to rise without any countering measures in place. There are no hedge funds we track holding positions in the company.

Disclosure: Jodor Jalit holds no position in any of the mentioned stocks.

Recommended Reading:

4 Stocks Insiders Are Buying… And Why You Should Care

Blackberry Co-Founder Mike Lazaridis Ups Stake to 8% in Bid for Buyout

CEO John Hart is Bullish on PICO Holdings

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!